Job Recruitment Website - Recruitment portal - The development course of Shandong Xinde Technology Co., Ltd.

The development course of Shandong Xinde Technology Co., Ltd.

1999, Zhucheng Xinde Pharmaceutical Co., Ltd. was founded by Mr. Li Chaoyang, the chairman of the board.

In 2000, the sales revenue of Zhucheng Xinde Pharmaceutical Co., Ltd. increased by 300%;

200 1, Zhucheng Xinde Pharmaceutical Co., Ltd. ranked first in the sales of therapeutic drugs in poultry industry in China;

In 2002, Zhucheng Xinde Pharmaceutical Co., Ltd. was renamed as "Shandong Xinde Pharmaceutical Co., Ltd.";

In April 2002, Qingdao Xinde Pharmaceutical Co., Ltd. was incorporated in Laoshan District, mainly engaged in the sales of imported veterinary biological products;

In 2004, the "Shun Tak" trademark was recognized as a famous trademark in Shandong Province;

From June 5438 to February 2004, Xinde Pharmaceutical cooperated with Beijing Academy of Agriculture and Forestry to establish Beijing Xin Dewit Technology Co., Ltd., and Xinde Pharmaceutical held 60% of the shares and invested in the construction of Xin Dewit Biological Products Industrial Park.

In 2005, Shun Tak Pharmaceutical invested in the construction of Shun Tak Biotechnology Industrial Park covering an area of 100 mu in Zhucheng, and the enzyme preparation project was officially put into operation in 165438+ 10.

In April, 2005, Xinde Pharmaceutical acquired Sichuan Huaxi Animal Pharmaceutical Co., Ltd., the largest manufacturer of veterinary needles in China, which complemented the original business of Xinde Company.

In September, 2006, Shandong Xinde Pharmaceutical Co., Ltd. invested heavily to build six GMP workshops in Xinde Science and Technology Industrial Park. Nine production lines that can produce eleven dosage forms, such as powder, powder, premix, small-volume injection, oral liquid, tablet, solid-liquid disinfectant and raw materials, all passed the GMP certification of the Ministry of Agriculture.

In September 2007, Shandong Xinde Pharmaceutical Co., Ltd. was officially renamed as Shandong Xinde Technology Co., Ltd., which became an important milestone in the history of enterprise development.

From June 5438 to February 2007, Shandong Shunde Technology Co., Ltd. was selected as one of the "2007 China 100 Fast Companies" and one of the top ten "Fast Growth Companies".

In June 2008, the enterprise center of Shandong Shunde Technology Co., Ltd. was recognized as the provincial key enterprise technology center;

In February 2009, the yolk antibody workshop of Shandong Xinde Technology Co., Ltd. officially passed the acceptance of GMP expert group, which is the second yolk antibody workshop of veterinary biological products in China and the first yolk antibody workshop in Shandong that passed GMP acceptance, marking that the company's biological products production field has entered the domestic leading level;

From June 5438 to February 2009, the transfer factor workshop of Shandong Xinde Technology Co., Ltd. officially passed the acceptance of GMP expert group. This is the first transfer factor GMP workshop built and accepted in China. The acceptance of this project will provide new high-tech products for the prevention and control of animal diseases, with no chemical residue, no environmental pollution, high safety and excellent curative effect, which will provide a strong guarantee for the promotion of green farming and a strong support for the next development of Xinde Company.

20 10 July, Xinde Science and Technology cooperated with Zhucheng Charity Federation in Shandong Province to establish a charity fund of 7.5 million yuan, which was specially used to help poor children in rural areas and poor students in agricultural colleges.

20 10 In September, Shun Tak Technology was awarded the title of "Top 50 Veterinary Drug Manufacturers in China in 2009" by China Animal Health Products Association.

20 10 1 1, Shunde Science and Technology Animal Vaccine Avian Influenza Project passed the GMP acceptance of the Ministry of Agriculture and became the first enterprise in China to produce avian influenza vaccine by cell suspension culture process.

20 1 1 February, Beijing company's R&D center won the certificate of "Beijing enterprise technology center", which is another honor after the R&D center was recognized as "Beijing scientific and technological research and development institution" and Beijing company was recognized as "national high-tech enterprise", marking that Beijing company's scientific research strength has entered a new height.

On August 20 1 1, we signed a cooperation agreement with Professor Jiang Shuxing, an internationally renowned animal nutrition expert and Donghai University in Taiwan Province Province, which marked a breakthrough in the introduction of overseas talents by Xinde Technology, which will strongly promote the company's scientific and technological innovation and enhance the high-end service level of technology.

On September 20 1 1, Xinde Hope Primary School in Xuanen County donated by the company was formally established in Jiaoyuan Town, Xuanen County, Enshi Autonomous Prefecture, Hubei Province. This is another good deed of the company in public welfare after the establishment of a charity fund of 7.5 million yuan in cooperation with Zhucheng Charity Federation last year and donation to Hope Project.